Skip to main navigation
Company Logo
  • About
    • About Overview
    • Leadership
    • Careers
  • Product
    • RECELL® System
  • Clinical Development
    • Pipeline/Clinical Trials
    • Patient Outcomes
    • Proof Assets
  • News & Media
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials
    • Annual Reports & Proxy
    • Stock Information
    • Corporate Governance
    • FAQ
    • Email Alerts
    • Contact
  • Contact
  • Search
  • Overview
  • Press Releases
  • Events & Presentations
  • Financials
  • Annual Reports & Proxy
  • Stock Information
  • Corporate Governance
  • FAQ
  • Email Alerts
  • Contact
global

Investors: ASX Filings

  • SEC Filings
  • ASX Filings
June 7, 2023
Statement of CDIs On Issue 41 KB
June 7, 2023
Updated Results of 2023 Annual General Meeting 263.9 KB
June 7, 2023
Avita Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects 276.8 KB
June 7, 2023
Schedule 14A 1.1 MB
June 6, 2023
Annual Meeting of Stockholders 2.9 MB
May 11, 2023
Avita Medical, Inc Financial Results for Quarter Ending 31, March 2023 2.4 MB
May 11, 2023
Avita Medical Reports First Quarter Financial Results and Affirms Full Year Guidance 508.9 KB
May 11, 2023
Avita Medical, Inc Financial Results for Quarter Ending 31, March 2023 2.4 MB
April 20, 2023
Avita Medical to Announce First Quarter 2023 Financial Results 199.8 KB
April 14, 2023
Form S-3 423.2 KB
April 13, 2023
Avita Medical Announces Update to Automation Device 244.8 KB
April 6, 2023
Statement of CDIs On Issue 40.7 KB
April 5, 2023
Statement of CDIs On Issue 39.2 KB
March 23, 2023
Avita Medical Appoints New Non-Executive Member to the Board of Directors 208.8 KB
March 2, 2023
AVITA Medical to Present at TD Cowen Health Care Conference - March 2, 2023 256.9 KB
March 2, 2023
Appendix 3G Notification regarding unquoted securities - AVH - March 2, 2023 43.3 KB
March 2, 2023
Appendix 3H (Notification of cessation of securities) - March 2, 2023 49.4 KB
March 2, 2023
Cleansing Notice under section 708A(5)(e) of the Corporations Act - March 2, 2023 307.9 KB
February 28, 2023
Appendix 3G Notification regarding unquoted securities - AVH - February 28, 2023 47.4 KB
February 26, 2023
AVITA Medical to Host Investor Webinar Briefing - February 26, 2023 196.7 KB
February 23, 2023
AVITA Medical Reports Fourth Quarter 2022 Results - February 23, 2023 620.5 KB
February 23, 2023
Appendix 4G and Corporate Governance Statement - February 23, 2023 934.4 KB
February 23, 2023
Appendix 4E and Annual Report (Form 10K) - February 23, 2023 1.9 MB
February 23, 2023
Q4 2022 Investor Presentation 1.7 MB
February 9, 2023
AVITA Medical to Announce Fourth Quarter 2022 Results - February 9, 2023 237.9 KB
February 9, 2023
Statement of CDIs On Issue 41.1 KB
February 6, 2023
Appendix 3H (Notification of cessation of securities) 42.7 KB
January 26, 2023
Appendix 3G - Notification regarding unquoted securities - AVH - January 26, 2023 44.2 KB
January 26, 2023
Cleansing Notice under section 708A(5)(e) of the Corporations Act - January 26, 2023 308.4 KB
January 19, 2023
AVITA Medical Announces Management Changes and Earnings Call - Jan 19, 2023 281.5 KB
January 11, 2023
Appendix 3G Notification regarding unquoted securities - AVH - Jan 11, 2023 47.5 KB
January 8, 2023
Statement of CDIs On Issue 43.7 KB
December 23, 2022
Avita Medical, Inc. (ASX:AVH) Cleansing Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) 281.1 KB
December 23, 2022
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 41.5 KB
December 22, 2022
Change of Director's Interest Notice - Suzanne Crowe 372.8 KB
December 22, 2022
Change of Director's Interest Notice - Jeremy Curnock Cook 370.2 KB
December 22, 2022
Change of Director's Interest Notice - James Corbett 372.1 KB
December 22, 2022
Change of Director's Interest Notice - Louis Panaccio 402.9 KB
December 22, 2022
Change of Director's Interest Notice - Jan Stern Reed 370.1 KB
December 19, 2022
Appendix 3Y Change of Director's Interest Notice 339.5 KB
December 19, 2022
Appendix 3Y Change of Director's Interest Notice 338 KB
December 19, 2022
Appendix 3Y Change of Director's Interest Notice 340.5 KB
December 19, 2022
Appendix 3Y 337.7 KB
December 19, 2022
Appendix 3Y Change of Director's Interest Notice 368.4 KB
December 16, 2022
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 55.4 KB
December 12, 2022
Appendix 3Z 348.8 KB
October 11, 2022
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 42.9 KB
October 10, 2022
Avita Medical, Inc. Financial Results for Quarter Ending 30 September 2022 1.8 MB
September 9, 2022
Appendix 3Y 327.9 KB
August 19, 2022
Cleansing Notice 207.5 KB
August 17, 2022
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 40.5 KB
August 12, 2022
Second Quarter Results 368.5 KB
August 12, 2022
Half Year Report 2022 715.1 KB
August 5, 2022
Statement of CDI's on Issue 37.1 KB
July 22, 2022
Substantial Holder Notice 198.1 KB
July 10, 2022
Statement of CDIs on Issue 38.2 KB
July 6, 2022
May 2022 Appendix 3H - June 3, 2022 39.3 KB
July 6, 2022
June 2022 Appendix 3H - July 1st 2022 47.8 KB
July 6, 2022
AVITA Medical Corporate Presentation May 2022 - May 11, 2022 7 MB
July 6, 2022
Dr. Perry Appendix 3G - June 9, 2022 52.3 KB
July 6, 2022
Appendix 3Z - Louis Drapeau - May 5, 2022 368.9 KB
July 6, 2022
AVITA Medical Investor Webinar - June 2, 2022 131.5 KB
July 6, 2022
Change of Director's Interest Notice - Michael Perry - June 9, 2022 335.9 KB
July 6, 2022
RECELL System to be Presented at SCALE Dermatology Meeting - May 9, 2022 228.4 KB
July 6, 2022
May 2022 Appendix 4A - June 4, 2022 46.5 KB
July 6, 2022
AVITA to Annouce First Quarter 2022 Financial Results 4.28.22 185.4 KB
July 6, 2022
Avita Medical, Inc. Announces resignation of Loius Drapeau from the BOD 4.21.22 242.1 KB
July 6, 2022
Quarterly Financial Report (Form 10-Q) - May 12 2022 329 KB
July 6, 2022
Notice under Section 708A5(e) of the Corporations Act - June 9, 2022 259.6 KB
July 6, 2022
April 2022 Appendix 4A - May 5, 2022 40.4 KB
June 12, 2022
Statement of CDIs on Issue 38.6 KB
April 12, 2022
March 2022 4A 36 KB
April 12, 2022
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 45.5 KB
March 3, 2022
March Vesting RSU 33.3 KB
March 3, 2022
March Expire Options 25.5 KB
March 3, 2022
March 3Y 614.9 KB
March 2, 2022
March Cleansing 182.2 KB
March 1, 2022
4E Transition Period 2.7 MB
February 28, 2022
February 2022 4A 26.8 KB
February 28, 2022
December Final Press Release 326.5 KB
January 13, 2022
January 2022 4A 26.8 KB
January 12, 2022
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities 30.7 KB
January 12, 2022
Notification of cessation of +securities 23.2 KB
January 10, 2022
AVITA Medical Announces Preliminary Unaudited Results for the Quarter ended December 31, 2021 221 KB
January 7, 2022
Statement of CDIs on Issue 24.5 KB
January 6, 2022
AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Soft-Tissue Reconstruction 192.3 KB
January 5, 2022
AVITA Medical Establishes Proof of Concept for Novel Treatments Using Genetically-Modified Skin Cells 197.5 KB
November 8, 2021
First Quarter and Fiscal Year 2022 Financial Results 1.4 MB
September 23, 2021
Appendix 3Y Change of Director’s Interest Notice 217.2 KB
September 23, 2021
Appendix 3Y Change of Director’s Interest Notice 166.3 KB
September 9, 2021
September ASX 2021 Appendix 3Y 580.4 KB
September 9, 2021
Appendix 3Y Change of Director’s Interest Notice 238.7 KB
August 27, 2021
June ASX Appendix 4E for the 12-month period ending June 30, 2021 2.1 MB
August 26, 2021
Fourth Quarter and Fiscal Year 2021 Financial Results 365.6 KB
July 5, 2021
Appendix 3Y Change of Director’s Interest Notice 216.9 KB
July 5, 2021
Appendix 3Y Change of Director’s Interest Notice 216.9 KB
June 8, 2021
June ASX 2021 Appendix 3Y 393.4 KB
May 13, 2021
March 2021 Quarterly Report 693.6 KB
February 17, 2021
Half Year Financial Report for Fiscal Year 2021 324.3 KB
November 11, 2020
September 2020 Quarterly Report 334.8 KB
August 27, 2020
ASX Appendix 4E & 10K June 30, 2020 FINAL.pdf 1.1 MB
June 30, 2020
Appendix 3Y Change of Director’s Interest Notice 217.2 KB
June 30, 2020
Appendix 3Y Change of Director’s Interest Notice 216.4 KB
June 30, 2020
Appendix 3Y Change of Director’s Interest Notice 224.1 KB
April 29, 2020
March 2020 Quarterly Report 468.6 KB
February 19, 2020
December 2019 Half Year Report 1 MB
January 31, 2020
December 2019 Quarterly Report 337.4 KB
November 26, 2019
Results of Annual General Meeting 852.5 KB
October 31, 2019
AVH Press Release 4C Quarterly Report 31 October 2019 Final 412 KB
August 30, 2019
AVH Corporate Governance Statement 2019 FINAL 382.8 KB
July 31, 2019
AVH Press Release 4 C Quarterly Report 30 June 2019 Final 407.4 KB
June 24, 2019
Download 2019 Full Financial Report 1.6 MB
April 30, 2019
March 2019 Quarterly Report 415.2 KB
March 3, 2019
2019 Concise Annual Report 1.8 MB
February 28, 2019
December 2018 Quarterly Report 835.2 KB
January 31, 2019
AVH Press Release 4C Quarterly Report 31 December 2018F 311.1 KB
January 1, 2019
2018 Concise Financial Report 2.9 MB
October 31, 2018
September 2018 Quarterly Report 339.8 KB
July 31, 2018
June 2018 Quarterly Report 299.9 KB
June 24, 2018
2018 Full Financial Report 1.2 MB
April 30, 2018
March 2018 Quarterly Report 209.2 KB
January 31, 2018
December 2017 Quarterly Report 208.6 KB
January 1, 2018
2017 Concise Annual Report 4.8 MB
December 31, 2017
December 2017 Half-Year Report 193.9 KB
October 30, 2017
September 2017 Quarterly Report 191.1 KB
July 28, 2017
June 2017 Quarterly Report 179.1 KB
June 24, 2017
2017 Full Financial Report 1.4 MB
April 28, 2017
March 2017 Quarterly Report 406.6 KB
January 1, 2017
2016 Concise Annual Report 887.2 KB
December 31, 2016
December 2016 Half-Year Report 395 KB
June 24, 2016
2016 Full Financial Report 3.3 MB
AVITA Medical, Inc. Logo with tag

Contact Investor Relations

Jessica Ekeberg
Director, Investor Relations
investor@avitamedical.com

Request Email Alerts
® 2023 AVITA Medical, Inc.
  • Terms of Use
  • Privacy Policy
  • CA Compliance
  • Social Media
  • CCPA
  • Compliance and Ethics
  • Important Safety Information

Social Media

  • Twitter (opens in new window)
  • Linkedin (opens in new window)